Private equity firm Bain Capital (BCSF) is paying $3.4 billion to buy a 350-year-old Japanese drugs group fighting diabetes ...

ShopMy has secured $77.5 million in Series B funding led by Bessemer Venture Partners and Bain Capital Ventures, with ...

Bain Capital will partner with Milacron’s current owner ... Our global platform invests across five focus areas: Private Equity, Growth & Venture, Capital Solutions, Credit & Capital Markets, and Real ...

Tech firms that speed up and automate brands’ partnerships with social-media influencers are becoming hot commodities as advertisers scramble to reach consumers online.

The provider of highly-engineered processing equipment and solutions will sell a 51% stake in the injection molding and extrusion business for $287 million.

Private equity firm Bain Capital plans to fully acquire Surgery Partners, one of the five largest operators of ambulatory surgery centers, for $3.2 billion.

The joint venture between Bain Capital and Evergreen has a portfolio of 34 facilities with a combined 1.5 million square feet. The venture also has buildings in cities including Portland ...

Bain Capital has agreed to acquire Tanabe Pharma, the pharma arm of Mitsubishi Chemical Group Corporation. The deal puts Tanabe Pharma at a valuation of about $3.3 billion. Founded in 1678, Tanabe ...

Bain Capital entered a deal to acquire Mitsubishi Tanabe Pharma Corporation (MTPC) from Mitsubishi Chemical Group for 510 ...

Blackstone joins other big investors such as ARCH Venture Partners and Bain Capital Life Sciences in pumping billions of dollars into the industry.